Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330(2):170–181. https://doi.org/10.1001/jama.2023.11305

Article  CAS  PubMed  Google Scholar 

Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing’s syndrome. Lancet (London, England) 402(10418):2237–2252. https://doi.org/10.1016/S0140-6736(23)01961-X

Article  PubMed  Google Scholar 

Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Biller BMK (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabet Endocrinol 9(12):847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Article  Google Scholar 

Dekkers OM, Horváth-Puhó E, Jørgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, Sørensen HT (2013) Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab 98(6):2277–2284. https://doi.org/10.1210/jc.2012-3582

Article  CAS  PubMed  Google Scholar 

Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabet Endocrinol 4(7):611–629. https://doi.org/10.1016/S2213-8587(16)00086-3

Article  CAS  Google Scholar 

Plotz CM, Knowlton AI, Ragan C (1952) The natural history of Cushing’s syndrome. Am J Med 13(5):597–614. https://doi.org/10.1016/0002-9343(52)90027-2

Article  CAS  PubMed  Google Scholar 

Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, Stewart PM (2022) The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107(8):2377–2388. https://doi.org/10.1210/clinem/dgac265

Article  PubMed  PubMed Central  Google Scholar 

Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, Pignatelli P (2023) A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci 24(4):3169. https://doi.org/10.3390/ijms24043169

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johannesdottir SA, Horváth-Puhó E, Dekkers OM, Cannegieter SC, Jørgensen JO, Ehrenstein V, Vandenbroucke JP, Pedersen L, Sørensen HT (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173(9):743–752. https://doi.org/10.1001/jamainternmed.2013.122

Article  CAS  PubMed  Google Scholar 

Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost: JTH 8(11):2450–2457. https://doi.org/10.1111/j.1538-7836.2010.04044.x

Article  CAS  PubMed  Google Scholar 

Isand K, Feelders R, Brue T, Toth M, Deutschbein T, Reincke M, Kršek M, Santos A, Demtröder F, Chabre O, Strasburger CJ, Aulinas Maso A, Volke V, Pereira AM, Lohmann R, Gich Saladich I, Ercusyn Study Group, Webb SM, Wass J, Valassi E (2024) High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery. Eur J Endocrinol 190(1):75–85. https://doi.org/10.1093/ejendo/lvad176

Article  PubMed  Google Scholar 

van Haalen FM, Kaya M, Pelsma ICM, Dekkers OM, Biermasz NR, Cannegieter SC, Huisman MV, van Vlijmen BJM, Feelders RA, Klok FA, Pereira AM, Cushing EERN, Endo-ERN Cushing and Thrombosis Study Group (2022) Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet J Rare Dis 17(1):178. https://doi.org/10.1186/s13023-022-02320-x

Article  PubMed  PubMed Central  Google Scholar 

Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96(11):3525–3532. https://doi.org/10.1210/jc.2011-1661

Article  CAS  PubMed  Google Scholar 

Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M (2019) Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing’s syndrome: a systematic meta-analysis. Front Endocrinol 9:805. https://doi.org/10.3389/fendo.2018.00805

Article  Google Scholar 

Suarez MG, Stack M, Hinojosa-Amaya JM, Mitchell MD, Varlamov EV, Yedinak CG, Cetas JS, Sheppard B, Fleseriu M (2019) Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc 4(2):033. https://doi.org/10.1210/jendso/bvz033

Article  Google Scholar 

Babic B, De Roulet A, Volpe A, Nilubol N (2018) Is VTE prophylaxis necessary on discharge for patients undergoing adrenalectomy for cushing syndrome? J Endocr Soc 3(2):304–313. https://doi.org/10.1210/js.2018-00278

Article  PubMed  PubMed Central  Google Scholar 

Rudman Y, Fleseriu M, Dery L, Masri-Iraqi H, Sasson L, Shochat T, Kushnir S, Shimon I, Akirov A (2024) Endogenous Cushing’s syndrome and cancer risk. Eur J Endocrinol 191(2):223–231. https://doi.org/10.1093/ejendo/lvae098

Article  PubMed  Google Scholar 

Puglisi S, Perini AME, Botto C, Oliva F, Terzolo M (2024) Long-term consequences of Cushing syndrome: a systematic literature review. J Clin Endocrinol Metab 109(3):e901–e919. https://doi.org/10.1210/clinem/dgad453

Article  PubMed  Google Scholar 

van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA (2013) Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol 78(4):481–488. https://doi.org/10.1111/cen.12094

Article  CAS  Google Scholar 

Vogel F, Braun L, Zopp S, Nowak E, Schreiner J, Benz I, Rubinstein G, Künzel H, Ritzel K, Kroiss M, Honegger J, Beuschlein F, Schilbach K, Teupser D, Bidlingmaier M, Reincke M (2023) Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing’s syndrome. Eur J Endocrinol 188(4):375–384. https://doi.org/10.1093/ejendo/lvad041

Article  PubMed  Google Scholar 

Terzolo M, Allasino B, Pia A, Peraga G, Daffara F, Laino F, Ardito A, Termine A, Paccotti P, Berchialla P, Migliaretti G, Reimondo G (2014) Surgical remission of Cushing’s syndrome reduces cardiovascular risk. Eur J Endocrinol 171(1):127–136. https://doi.org/10.1530/EJE-13-0555

Article  CAS  PubMed  Google Scholar 

Tirosh A, Lodish M, Lyssikatos C, Belyavskaya E, Feelders RA, Stratakis CA (2017) Coagulation profile in patients with different etiologies for Cushing syndrome: a prospective observational study. Horm Metab Res Horm Stoffwechselforschung Horm et Metab 49(5):365–371. https://doi.org/10.1055/s-0043-100113

Article  CAS  Google Scholar 

Zilio M, Mazzai L, Sartori MT, Barbot M, Ceccato F, Daidone V, Casonato A, Saggiorato G, Noventa F, Trementino L, Prandoni P, Boscaro M, Arnaldi G, Scaroni C (2016) A venous thromboembolism risk assessment model for patients with Cushing’s syndrome. Endocrine 52(2):322–332. https://doi.org/10.1007/s12020-015-0665-z

Article  CAS  PubMed  Google Scholar 

Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H (2009) Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32(2):169–174. https://doi.org/10.1007/BF03345709

Article  CAS  PubMed  Google Scholar 

Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing’s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783–791. https://doi.org/10.1530/EJE-10-0583

Article  CAS  PubMed  Google Scholar 

Feelders RA, Nieman LK (2022) Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary 25(5):746–749. https://doi.org/10.1007/s11102-022-01261-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koraćević G, Stojanović M, Petrović S, Simić D, Sakač D, Vlajković M, Stevic M, Kocić M, Đorđević M, Koraćević M (2020) Cushing’s syndrome, a risk factor for venous thromboembolism is a candidate for guidelines. Acta Endocr (Bucharest, Romania : 2005) 16(2):123–128. https://doi.org/10.4183/aeb.2020.123

Article  Google Scholar